Comprehensive Care TeamResearch FocusedVirtual Care Available
You’re looking at a large academic MS center where care is organized around both treatment and research. You’ll likely appreciate the broad team, advanced testing, infusion services, and the option for virtual visits. Because this is a busy specialty center, your care may involve multiple teams working together across a large program.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care5/5
About Mellen Center for MS Treatment & Research
AI summary of this centre's website
This center combines high-volume MS care with active research within a large academic medical setting. It is also known for the first 7 Tesla MRI in Northeast Ohio, which adds advanced imaging capability to the care experience.
Mellen Center for MS Treatment & Research cares for people with multiple sclerosis and related neurologic conditions, including pediatric MS, optic neuritis, transverse myelitis, and neuromyelitis optica. You can receive care from a multidisciplinary team that includes neurologists, nurses, therapists, psychologists, social workers, and research specialists. Services include imaging and diagnostic testing, rehabilitation, infusion therapy, health psychology, and alternative and complementary medicine appointments. The center also offers virtual visits, MyChart support, and a strong connection to MS research.
Good to know
Virtual visits are available for both new and existing patients.
Onsite infusion services are available.
MyChart lets you message your care team and manage appointments.
Patients can request image uploads and image copies.
A care coordinator is available to help support your visit planning.
Mellen Center for Multiple Sclerosis brings together a large team focused on MS care and research within a major academic health system. Patients can access in-person and virtual visits, infusion services, rehabilitation, and a patient portal for messaging and appointment management. The center also stands out for offering the first 7 Tesla MRI in Northeast Ohio.
Specialized Programs
Pediatric multiple sclerosis
Rehabilitation
Health psychology
Alternative and complementary medicine appointments
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
FAQs from Mellen Center for MS Treatment & Research
The center treats multiple sclerosis, including relapsing-remitting, primary progressive, and secondary progressive forms. It also cares for pediatric MS, neuromyelitis optica, anti-MOG-associated disease, optic neuritis, transverse myelitis, and acute disseminated encephalomyelitis.
Yes. The center has active clinical trials and research programs, along with a dedicated MS research focus.
Yes, the center has an onsite infusion model and offers infusion services. IV steroids are also among the treatments mentioned.
The center offers MRI, including 7 Tesla MRI, along with evoked potentials, lumbar puncture, neuropsychological evaluations, optical coherence tomography, and the Multiple Sclerosis Performance Test.
You can use MyChart for messaging and appointment management. The center also offers virtual visits and provides image request and upload support.
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.